Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Stockholders Equity of -$375.5 thousand for fiscal year 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$375.5K | -147.4% |
| 2023 | -$151.8K | +84.0% |
| 2022 | -$951.3K | -244.9% |
| 2021 | -$275.8K | -2052.8% |
| 2020 | -$12.8K | — |
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed a decrease of -147.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2024 period, Cordyceps Sunshine Biotech Holdings Co., Ltd.’s stockholders equity has declined by 2831.2% (from -$12.8 thousand to -$375.5 thousand).
- The most recent figure is from Cordyceps Sunshine Biotech Holdings Co., Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 13, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: